392 related articles for article (PubMed ID: 15643505)
21. Clinicopathological features and microsatellite instability (MSI) in colorectal cancers from African Americans.
Ashktorab H; Smoot DT; Farzanmehr H; Fidelia-Lambert M; Momen B; Hylind L; Iacosozio-Dononue C; Carethers JM; Goel A; Boland CR; Giardiello FM
Int J Cancer; 2005 Oct; 116(6):914-9. PubMed ID: 15856472
[TBL] [Abstract][Full Text] [Related]
22. Microsatellite instability, loss of heterozygosity, and loss of hMLH1 and hMSH2 protein expression in endometrial carcinoma.
Peiró G; Diebold J; Lohse P; Ruebsamen H; Lohse P; Baretton GB; Löhrs U
Hum Pathol; 2002 Mar; 33(3):347-54. PubMed ID: 11979377
[TBL] [Abstract][Full Text] [Related]
23. Methylation of the hMLH1 promoter but no hMLH1 mutations in sporadic gastric carcinomas with high-level microsatellite instability.
Bevilacqua RA; Simpson AJ
Int J Cancer; 2000 Jul; 87(2):200-3. PubMed ID: 10861474
[TBL] [Abstract][Full Text] [Related]
24. Characterization of mutator pathway in younger-age-onset colorectal adenocarcinomas.
Roh SA; Kim HC; Kim JS; Kim JC
J Korean Med Sci; 2003 Jun; 18(3):387-91. PubMed ID: 12808326
[TBL] [Abstract][Full Text] [Related]
25. The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas.
Cunningham JM; Kim CY; Christensen ER; Tester DJ; Parc Y; Burgart LJ; Halling KC; McDonnell SK; Schaid DJ; Walsh Vockley C; Kubly V; Nelson H; Michels VV; Thibodeau SN
Am J Hum Genet; 2001 Oct; 69(4):780-90. PubMed ID: 11524701
[TBL] [Abstract][Full Text] [Related]
26. BRAF mutations in colorectal carcinoma suggest two entities of microsatellite-unstable tumors.
Lubomierski N; Plotz G; Wormek M; Engels K; Kriener S; Trojan J; Jungling B; Zeuzem S; Raedle J
Cancer; 2005 Sep; 104(5):952-61. PubMed ID: 16015629
[TBL] [Abstract][Full Text] [Related]
27. Expression of hMLH1 is inactivated in the gastric adenomas with enhanced microsatellite instability.
Baek MJ; Kang H; Kim SE; Park JH; Lee JS; Paik YK; Kim H
Br J Cancer; 2001 Oct; 85(8):1147-52. PubMed ID: 11710827
[TBL] [Abstract][Full Text] [Related]
28. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1.
Thibodeau SN; French AJ; Cunningham JM; Tester D; Burgart LJ; Roche PC; McDonnell SK; Schaid DJ; Vockley CW; Michels VV; Farr GH; O'Connell MJ
Cancer Res; 1998 Apr; 58(8):1713-8. PubMed ID: 9563488
[TBL] [Abstract][Full Text] [Related]
29. Alterations of DNA mismatch repair proteins and microsatellite instability levels in gastric cancer cell lines.
Yao Y; Tao H; Kim JJ; Burkhead B; Carloni E; Gasbarrini A; Sepulveda AR
Lab Invest; 2004 Jul; 84(7):915-22. PubMed ID: 15133479
[TBL] [Abstract][Full Text] [Related]
30. High thymidylate synthase expression in colorectal cancer with microsatellite instability: implications for chemotherapeutic strategies.
Ricciardiello L; Ceccarelli C; Angiolini G; Pariali M; Chieco P; Paterini P; Biasco G; Martinelli GN; Roda E; Bazzoli F
Clin Cancer Res; 2005 Jun; 11(11):4234-40. PubMed ID: 15930362
[TBL] [Abstract][Full Text] [Related]
31. Microsatellite instability in colorectal carcinoma. The comparison of immunohistochemistry and molecular biology suggests a role for hMSH6 [correction of hMLH6] immunostaining.
Rigau V; Sebbagh N; Olschwang S; Paraf F; Mourra N; Parc Y; Flejou JF
Arch Pathol Lab Med; 2003 Jun; 127(6):694-700. PubMed ID: 12741892
[TBL] [Abstract][Full Text] [Related]
32. Origin of microsatellite instability in gastric cancer.
Halling KC; Harper J; Moskaluk CA; Thibodeau SN; Petroni GR; Yustein AS; Tosi P; Minacci C; Roviello F; Piva P; Hamilton SR; Jackson CE; Powell SM
Am J Pathol; 1999 Jul; 155(1):205-11. PubMed ID: 10393852
[TBL] [Abstract][Full Text] [Related]
33. Expression of mismatch repair enzymes, hMLH1 and hMSH2 is not associated with microsatellite instability and P53 protein accumulation in basal cell carcinoma.
Saetta AA; Aroni K; Stamatelli A; Lazaris AC; Patsouris E
Arch Dermatol Res; 2005 Sep; 297(3):99-107. PubMed ID: 16012876
[TBL] [Abstract][Full Text] [Related]
34. Microsatellite mutations of transforming growth factor-beta receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation.
Scott S; Kimura T; Ichinohasama R; Bergen S; Magliocco A; Reimer C; Kerviche A; Sheridan D; DeCoteau JF
Leuk Res; 2003 Jan; 27(1):23-34. PubMed ID: 12479849
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of microsatellite instability, hMLH1 expression and hMLH1 promoter hypermethylation in defining the MSI phenotype of colorectal cancer.
Arnold CN; Goel A; Compton C; Marcus V; Niedzwiecki D; Dowell JM; Wasserman L; Inoue T; Mayer RJ; Bertagnolli MM; Boland CR
Cancer Biol Ther; 2004 Jan; 3(1):73-8. PubMed ID: 14726676
[TBL] [Abstract][Full Text] [Related]
36. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability.
Fleisher AS; Esteller M; Wang S; Tamura G; Suzuki H; Yin J; Zou TT; Abraham JM; Kong D; Smolinski KN; Shi YQ; Rhyu MG; Powell SM; James SP; Wilson KT; Herman JG; Meltzer SJ
Cancer Res; 1999 Mar; 59(5):1090-5. PubMed ID: 10070967
[TBL] [Abstract][Full Text] [Related]
37. Germline, somatic and epigenetic events underlying mismatch repair deficiency in colorectal and HNPCC-related cancers.
Yuen ST; Chan TL; Ho JW; Chan AS; Chung LP; Lam PW; Tse CW; Wyllie AH; Leung SY
Oncogene; 2002 Oct; 21(49):7585-92. PubMed ID: 12386821
[TBL] [Abstract][Full Text] [Related]
38. Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status.
Oliveira C; Westra JL; Arango D; Ollikainen M; Domingo E; Ferreira A; Velho S; Niessen R; Lagerstedt K; Alhopuro P; Laiho P; Veiga I; Teixeira MR; Ligtenberg M; Kleibeuker JH; Sijmons RH; Plukker JT; Imai K; Lage P; Hamelin R; Albuquerque C; Schwartz S; Lindblom A; Peltomaki P; Yamamoto H; Aaltonen LA; Seruca R; Hofstra RM
Hum Mol Genet; 2004 Oct; 13(19):2303-11. PubMed ID: 15294875
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors.
Marcus VA; Madlensky L; Gryfe R; Kim H; So K; Millar A; Temple LK; Hsieh E; Hiruki T; Narod S; Bapat BV; Gallinger S; Redston M
Am J Surg Pathol; 1999 Oct; 23(10):1248-55. PubMed ID: 10524526
[TBL] [Abstract][Full Text] [Related]
40. Not hMSH2 but hMLH1 is frequently silenced by hypermethylation in endometrial cancer but rarely silenced in pancreatic cancer with microsatellite instability.
Kondo E; Furukawa T; Yoshinaga K; Kijima H; Semba S; Yatsuoka T; Yokoyama T; Fukushige S; Horii A
Int J Oncol; 2000 Sep; 17(3):535-41. PubMed ID: 10938395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
